ID: ALA4582430

Max Phase: Preclinical

Molecular Formula: C15H23NOS

Molecular Weight: 265.42

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=C(CCCCCCc1ccsc1)N1CCCC1

Standard InChI:  InChI=1S/C15H23NOS/c17-15(16-10-5-6-11-16)8-4-2-1-3-7-14-9-12-18-13-14/h9,12-13H,1-8,10-11H2

Standard InChI Key:  KOQUCVOBYNEOCX-UHFFFAOYSA-N

Associated Targets(non-human)

N-acylethanolamine-hydrolyzing acid amidase 372 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 265.42Molecular Weight (Monoisotopic): 265.1500AlogP: 3.86#Rotatable Bonds: 7
Polar Surface Area: 20.31Molecular Species: NEUTRALHBA: 2HBD: 0
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.66CX LogD: 3.66
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.69Np Likeness Score: -1.55

References

1. Zhou P, Xiang L, Zhao D, Ren J, Qiu Y, Li Y..  (2019)  Synthesis, biological evaluation, and structure activity relationship (SAR) study of pyrrolidine amide derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors.,  10  (2): [PMID:30931090] [10.1039/C8MD00432C]

Source